Health Catalyst, Inc.

HCAT

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
HCAT
CIK0001636422
SIC7370
SectorServices
Industry CategoryComputer Software
Industry GroupServices – Computer Programming And Data Processing

Contact

Address10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095
Website healthcatalyst.com
Phone801-708-6800
CEODaniel D. Burton
Employees1,200

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$316.09 million
Pre-Tax Income$-99.67 million
Net Income$-100.12 million
Net Income to Common$-100.12 million
EPS$-1.51
View All
Balance Sheet
Cash$50.71 million
Assets$616.18 million
Liabilities$268.63 million
Common Equity$347.55 million
Liabilities & Equity$616.18 million
View All
Cash Flow Statement
Calculations
NOPAT$-61.92 million
EBITDA$-41.16 million
Price to EarningsN/A
Price to Book$0.57
ROE-28.42%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Article Link

Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of +33.33% and +0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Article Link

Health Catalyst (NASDAQ:HCAT) Posts Q2 Sales In Line With Estimates But Stock Drops

Healthcare software provider Health Catalyst (NASDAQ:HCAT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 6.3% year on year to $80.72 million. On the other hand, next quarter’s revenue guidance of $75 million was less impressive, coming in 12% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was in line with analysts’ consensus estimates.

Article Link

Health Catalyst: Q2 Earnings Snapshot

On a per-share basis, the South Jordan, Utah-based company said it had a loss of 59 cents. Earnings, adjusted for one-time gains and costs, came to 4 cents per share. The results topped Wall Street expectations.

Article Link

Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints.

Article Link